Organisation paid for research Program year 2025 Source: CMS Open Payments

WCG IRB Inc

Neither a doctor nor a teaching hospital

Research payments

$120,307

105 payments

Through program year 2025, WCG IRB Inc is reported as receiving $120,307 in research payments, across 105 payments.

By program year

5 rows
Year Kind Amount Payments
2025 Research $37,964 14
2024 Research $18,088 26
2023 Research $16,161 25
2022 Research $12,951 14
2021 Research $35,143 26

Breakdown

Who paid Research payments · program years 2021–2025
  1. Stryker Corporation $30,466 24 payments
  2. Genentech, Inc. $17,922 26 payments
  3. Zynex Medical, Inc. $14,554 1 payment
  4. Abbott Laboratories $9,213 1 payment
  5. Clovis Oncology, Inc. $8,037 5 payments
  6. Aesculap Biologics, LLC $7,180 12 payments
  7. SK Life Science, Inc. $6,593 11 payments
  8. Jazz Pharmaceuticals Inc. $6,503 4 payments
  9. Hoffmann-La Roche Limited $5,249 6 payments
  10. pharmaand GmbH $4,864 2 payments
Studies the money was for Research payments · program years 2021–2025
  1. Randomized Blinded Evaluation of the Effects of TENS and IFC Compared to a Sham Device and SOC in Patients with Non-Specific CLBP $14,554 1 payment
  2. PH Iib of Astegolimab in COPD $10,334 16 payments
  3. NCT06772493--ViewFlex X ICE First-in-Human Study $9,213 1 payment
  4. Securfit Advanced Outcomes Study $8,400 6 payments
  5. A Study of Rucaparib Versus Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency (TRITON3) $8,037 5 payments
  6. Ph1b to evaluate GDC 1971 furmonertinib in EGFRmt NSCLC $7,694 8 payments
  7. Novocart 3D for the Treatment of Articular Cartilage of the Knee (N3d) $6,846 11 payments
  8. Ykp509c003 $6,593 11 payments
  9. ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study $6,503 4 payments
  10. Trident II Tritanium Outcomes Study $5,420 4 payments
What the money was spent on Research payments · program years 2021–2025
  1. Medical research writing or publication $14,554 1 payment

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record